{"name":"Teva Pharmaceuticals USA","slug":"teva-pharmaceuticals-usa","ticker":"","exchange":"","domain":"tevausa.com","description":"Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.","hq":"","founded":0,"employees":"~46,000","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"1991-01-01","label":"Cefzil first approved","drug":"Cefzil","drugSlug":"cefprozil","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":7,"colorKey":"immunology","drugs":[{"name":"FEMCON® Fe","genericName":"FEMCON® Fe","slug":"femcon-fe","indication":"Contraception (prevention of pregnancy)","status":"marketed"},{"name":"Activella®","genericName":"Activella®","slug":"activella","indication":"Other","status":"marketed"},{"name":"Azelastine hydrochloride and Fluticasone propionate","genericName":"Azelastine hydrochloride and Fluticasone propionate","slug":"azelastine-hydrochloride-and-fluticasone-propionate","indication":"Other","status":"marketed"},{"name":"Imvexxy","genericName":"Imvexxy","slug":"imvexxy","indication":"Other","status":"marketed"},{"name":"Lamictal®","genericName":"Lamictal®","slug":"lamictal","indication":"Other","status":"marketed"},{"name":"Paxil®","genericName":"Paxil®","slug":"paxil","indication":"Other","status":"marketed"},{"name":"Zofran®","genericName":"Zofran®","slug":"zofran","indication":"Other","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"AKLIEF®","genericName":"AKLIEF®","slug":"aklief","indication":"Acne vulgaris","status":"marketed"},{"name":"Trifarotene 0.005 % Topical Cream","genericName":"Trifarotene 0.005 % Topical Cream","slug":"trifarotene-0-005-topical-cream","indication":"Acne vulgaris","status":"phase_3"},{"name":"YAZ®","genericName":"YAZ®","slug":"yaz","indication":"Contraception","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Trileptal®","genericName":"Trileptal®","slug":"trileptal","indication":"Partial-onset seizures (monotherapy and adjunctive therapy in adults and children)","status":"marketed"},{"name":"Imitrex®","genericName":"Imitrex®","slug":"imitrex","indication":"Acute treatment of migraine with or without aura","status":"marketed"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"neuroscience","drugs":[{"name":"VTAMA®","genericName":"VTAMA®","slug":"vtama","indication":"Plaque psoriasis","status":"marketed"},{"name":"Tapinarof Cream 1%","genericName":"Tapinarof Cream 1%","slug":"tapinarof-cream-1","indication":"Moderate to severe plaque psoriasis","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"infectious","drugs":[{"name":"Augmentin®","genericName":"Augmentin®","slug":"augmentin","indication":"Bacterial infections of the ear, nose, and throat","status":"marketed"},{"name":"Cefzil","genericName":"cefprozil","slug":"cefprozil","indication":"Acute Moraxella catarrhalis bronchitis","status":"marketed"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Cozaar®","genericName":"Cozaar®","slug":"cozaar","indication":"Hypertension","status":"marketed"}]}],"pipeline":[{"name":"AKLIEF®","genericName":"AKLIEF®","slug":"aklief","phase":"marketed","mechanism":"Retinoic acid receptor alpha, Retinoic acid receptor beta, Retinoic acid receptor gamma","indications":["Acne vulgaris"],"catalyst":""},{"name":"FEMCON® Fe","genericName":"FEMCON® Fe","slug":"femcon-fe","phase":"marketed","mechanism":"FEMCON Fe is an oral contraceptive that prevents pregnancy by suppressing ovulation through a combination of ethinyl estradiol and norethindrone, while the ferrous fumarate component replaces iron lost during menstruation.","indications":["Contraception (prevention of pregnancy)","Regulation of menstrual cycle"],"catalyst":""},{"name":"Trifarotene 0.005 % Topical Cream","genericName":"Trifarotene 0.005 % Topical Cream","slug":"trifarotene-0-005-topical-cream","phase":"phase_3","mechanism":"Trifarotene is a retinoic acid receptor gamma (RAR-gamma) agonist that modulates the expression of genes involved in cell differentiation and proliferation.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Trileptal®","genericName":"Trileptal®","slug":"trileptal","phase":"marketed","mechanism":"Oxcarbazepine blocks voltage-gated sodium channels in neuronal membranes, reducing repetitive neuronal firing and stabilizing hyperexcited neural tissue.","indications":["Partial-onset seizures (monotherapy and adjunctive therapy in adults and children)","Generalized tonic-clonic seizures (adjunctive therapy)","Bipolar disorder (off-label use)"],"catalyst":""},{"name":"VTAMA®","genericName":"VTAMA®","slug":"vtama","phase":"marketed","mechanism":"VTAMA is a topical retinoid that binds to and activates retinoid X receptors (RXR) to promote skin cell differentiation and reduce inflammation in psoriasis.","indications":["Plaque psoriasis"],"catalyst":""},{"name":"Activella®","genericName":"Activella®","slug":"activella","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Augmentin®","genericName":"Augmentin®","slug":"augmentin","phase":"marketed","mechanism":"Augmentin combines amoxicillin (a beta-lactam antibiotic) with clavulanic acid (a beta-lactamase inhibitor) to kill bacteria and overcome antibiotic resistance.","indications":["Bacterial infections of the ear, nose, and throat","Respiratory tract infections","Urinary tract infections","Skin and soft tissue infections","Bone and joint infections"],"catalyst":""},{"name":"Azelastine hydrochloride and Fluticasone propionate","genericName":"Azelastine hydrochloride and Fluticasone propionate","slug":"azelastine-hydrochloride-and-fluticasone-propionate","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Cefzil","genericName":"cefprozil","slug":"cefprozil","phase":"marketed","mechanism":"Small molecule","indications":["Acute Moraxella catarrhalis bronchitis","Acute bacterial bronchitis","Acute bacterial sinusitis","Acute exacerbation of chronic bronchitis","Acute otitis media"],"catalyst":""},{"name":"Cozaar®","genericName":"Cozaar®","slug":"cozaar","phase":"marketed","mechanism":"Cozaar blocks angiotensin II receptors on blood vessels and tissues, causing vasodilation and reducing blood pressure.","indications":["Hypertension","Diabetic nephropathy in patients with type 2 diabetes","Heart failure with reduced ejection fraction","Stroke risk reduction in hypertensive patients with left ventricular hypertrophy"],"catalyst":""},{"name":"Imitrex®","genericName":"Imitrex®","slug":"imitrex","phase":"marketed","mechanism":"Imitrex is a selective serotonin 5-HT1B/1D receptor agonist that constricts cranial blood vessels and inhibits neuropeptide release to relieve migraine headaches.","indications":["Acute treatment of migraine with or without aura","Acute treatment of cluster headache"],"catalyst":""},{"name":"Imvexxy","genericName":"Imvexxy","slug":"imvexxy","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Lamictal®","genericName":"Lamictal®","slug":"lamictal","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Paxil®","genericName":"Paxil®","slug":"paxil","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tapinarof Cream 1%","genericName":"Tapinarof Cream 1%","slug":"tapinarof-cream-1","phase":"phase_3","mechanism":"Tapinarof is a topical aryl hydrocarbon receptor agonist that modulates the immune response and reduces inflammation.","indications":["Moderate to severe plaque psoriasis"],"catalyst":""},{"name":"YAZ®","genericName":"YAZ®","slug":"yaz","phase":"marketed","mechanism":"YAZ is an oral contraceptive that prevents ovulation through a combination of ethinyl estradiol (estrogen) and drospirenone (progestin), while drospirenone also provides antimineralocorticoid activity.","indications":["Contraception","Acne vulgaris (FDA-approved indication)","Premenstrual dysphoric disorder (PMDD)"],"catalyst":""},{"name":"Zofran®","genericName":"Zofran®","slug":"zofran","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-02-20","type":"regulatory","source":"GlobeNewswire","summary":"U.S. Food and Drug Administration (FDA) Accepts Teva’s New - GlobeNewswire","headline":"U.S. Food and Drug Administration (FDA) Accepts Teva’s New","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNQUtnMlRjY2xRelJ1b1NFSUhqanNTRWVJdnZLanpwb1BUa1pKR21VOGY1Y1VhNEtaMlFlanJrMkxTWl91aElfR1VmSUk2MjBzUFRVeV8zbjFyZGhTQXNOVjhOVXRNZkRBbGllYkhmZ2RUbWI1RTBwd1M3UXhQOWptU2tEaU1odzVLSmc1VEgzdlBGTVNyY3pManlTNXlqdUxveU00ZzFBNWRyczNYT0ZQLXRRM3dNM2VZM1hjQ2UzSFJSRFU?oc=5","date":"2026-02-11","type":"regulatory","source":"Fierce Pharma","summary":"GSK, Teva quietly settle Coreg 'skinny label' dispute after long legal back-and-forth - Fierce Pharma","headline":"GSK, Teva quietly settle Coreg 'skinny label' dispute after long legal back-and-forth","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-28","type":"earnings","source":"simplywall.st","summary":"Teva Pharmaceutical Industries (NYSE:TEVA) Earnings Margin Recovery Challenges High P/E Valuation Narrative - simplywall.st","headline":"Teva Pharmaceutical Industries (NYSE:TEVA) Earnings Margin Recovery Challenges High P/E Valuation Narrative","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxQOXVCOVIxbmdHZXRpZU9ISTJXSW5iNU5BNnlIdm0yakQ5OEUwSmlJd1dFY1VQRmY3VjBfSUNXVEZZMWVwdG5KMW1nanZaVEh1eGI5NTRjUWpSb09aOUF4V1FsZk0wZXFzeDFLV3phdTczQjZFcVp1bDVUelpyamlGaFFKVVhfZ1ItYXRmX3NjdDV4ekM5VzFVbUtVSFJnVWlHX0ZFZ24zTEVLWnEzTEFOXy1SYngtNFQ0THhrcUhFOUJIWU1fMDZNSC1yTU55UmdNX2Nj?oc=5","date":"2025-11-05","type":"earnings","source":"Reuters","summary":"Teva Pharm profit tops estimates, says not worried by US tariffs - Reuters","headline":"Teva Pharm profit tops estimates, says not worried by US tariffs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBmUXN2NllEMzFjR0kyMFVvR2piZ2p4dERmMWhSSVl1MXhZUDE0ZDBRazMxMG5iRkdHeDhza0VmVUstbWlKelNhQ1ZkdVliRXljVmI5WUZWZnpMS3F0Uk1jcnNSWXhseXFfTFU1S2UzSnlPZm9hc2JWM21pMA?oc=5","date":"2025-11-05","type":"earnings","source":"Yahoo Finance","summary":"Here's What Key Metrics Tell Us About Teva Pharmaceutical Industries (TEVA) Q3 Earnings - Yahoo Finance","headline":"Here's What Key Metrics Tell Us About Teva Pharmaceutical Industries (TEVA) Q3 Earnings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPbGRjQkV4bkhtRWh1QWwyVzNuYjVPQjVDYldMdDBIZFZYM284ZWQxUnc2NktxdW9QcmdUS0liaWhGY1B5bF9fUU5hY0hLVERpRjgzbG5haU1PdWJBOVI1c2xUVUdXTUZBUm51d295dTFlcVlja0Jab09MdVVjQmhRSHpTcmFVaHFlaFpvTkItRWdmUzZsVE9xdHo2ajdXZHJ4UUtyRDBlV1lyMVg1MXRtZG9HR29NZnVudEdnNQ?oc=5","date":"2025-11-03","type":"regulatory","source":"Pharmacy Times","summary":"FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity - Pharmacy Times","headline":"FDA Announces Recall 580,000 Bottles of Prazosin Over Potential Carcinogenic Impurity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNUzhJSFZ0WWpLTlh2Nl8xazhmbTJ4RXZKeE9zSzl1dXBId1VzanpCNEVaSFFleFVLQ0REV2FsOUwyMmU1aVE5clRlaDRKYVFMb2h2RnBualhFeXpGUjFHY0UtdVFTTTBLTzd1clhzR20yNkMzRkFONFE3TWtUYVRweEVnMW1GeHluOExqTFZ2emRaWjA5eGJrODFYTzU3WVRIX2oxbE5Kb0tCSDlUd253cFhVRlY1bnVuOE5Fc1lUcWY?oc=5","date":"2025-08-29","type":"regulatory","source":"European Pharmaceutical Review","summary":"Teva wins US obesity approval for its GLP-1 generic liraglutide - European Pharmaceutical Review","headline":"Teva wins US obesity approval for its GLP-1 generic liraglutide","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZ25DTTFwVWFPVW9FMmpidVkxVHpPcHRQcnUyazhhaFZBMEVXUjgxSTdMc3BvWDE1cVhnVFNFUmlDRnRVRTBSUzNfbkF2cEN5S0owenk1emxjOHRlR1llckFXajdrSkhRRzRmc1RVUWpNM2liSkdvSkxSN010UUsyM1VnRTBMcHJ0U2ZWem9nTmxKX1pCeEpWdW03bXBsaVh0TnFDLUU1N1M?oc=5","date":"2025-08-22","type":"pipeline","source":"Seeking Alpha","summary":"Teva Pharmaceutical: Tariff Relief Clears The Way For Reinvention (NYSE:TEVA) - Seeking Alpha","headline":"Teva Pharmaceutical: Tariff Relief Clears The Way For Reinvention (NYSE:TEVA)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-13","type":"regulatory","source":"Medical Dialogues","summary":"Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA - Medical Dialogues","headline":"Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQYmpXMU9ZTjBFTmYzWVNxMGVPLTBtdVRMWkZHM0NPSHFDWmFQWjJZcFJQOGhrSDJTOWJaWVlYd1l0M0pHMm9pWi1GNEdETDJhZEI2Q3gtRkxJbzM5TFR6VUdhU2tZVU5FWGJBMjVJZFFtWlRyd2VVYk1pQjhyTE5TTTlUdm8zQ0dNZFRreUNGZHJwQ1hlNVpXVnJkU3ZoNDTSAaQBQVVfeXFMTXBaZDRna2JZLWpadWhSOXdCOTUyb0NqLWZtb2lLeFk2NVVsaDVVUy1fY3NoZjNQbWlVNVAzUUY3UU1iMjVtd2FVX2hkaFVKUlk4MWc5T29oZ2V4SG1DOUY5WV9mQ1dJVGt3Z0R1bVpCNDhaeWh3Um1QRzVybEY5ODRoek1jZXJGU3dpS01xZDFBXzNfcVFmY2ZUeXNDcWhHbW9pLTY?oc=5","date":"2025-08-13","type":"deal","source":"Express Pharma","summary":"Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA - Express Pharma","headline":"Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNRjJCNUx3VHkyUTJ4WmhQNnVFMXJVdjBRSEc5bEY2NFN5aU1GclpJRmdtR0tzeWtvc0Z2bGZZcnhUUmk2Rl8xcUY5Z0V4LVdNZnZ6cTQ2RWV2ZDA5eTBOaG5QQXYxMk5zYktlbTRTbXVtdUdvdDV3M0tSbnJSY0l1RzA1am5iNG83d3hIWnlGaWRjWDVBS2dqUnRHZDdKZHptT01FSjVLZS1CcVBITlRhOFhlSVQ0Zw?oc=5","date":"2025-07-30","type":"pipeline","source":"Fierce Pharma","summary":"Teva execs shrug off pharmaceutical tariff threat as turnaround strategy rolls forward - Fierce Pharma","headline":"Teva execs shrug off pharmaceutical tariff threat as turnaround strategy rolls forward","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOVEpVdW9NMkVmSnBVVU12NVBHNHo5c3gzM2xqemNoeEpYM2VvZlNJZWNJMGczaDRSeDk5VDVfdG42MTh1bGduYWNBTy1tRU9TNDVSNlFSdnVEbEFnSGxMYUc3OWhaME1LZlAtRmdJYVVNWXBzamZnbXNncVhMZndsUVF6TF9wci1KelhYMUQxRUdBQnZwaWlDZk56eC1TYkdBWkY4ejMzSnJGRGtiQllGN3JPakRLLVFyNi1BMnhVV1BMMTlkRk5ZOFVST2lnZGVKQ1NJV2treFlNU2ZvTFFob2FzTjE?oc=5","date":"2025-07-30","type":"regulatory","source":"Reuters","summary":"Teva Pharm's second-quarter profit boosted by branded drugs, US tariff questions remain - Reuters","headline":"Teva Pharm's second-quarter profit boosted by branded drugs, US tariff questions remain","sentiment":"neutral"}],"patents":[],"drugCount":17,"phaseCounts":{"marketed":15,"phase_3":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}